Hana Pharm Co., Ltd.
KSC: 293480.KS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Korea Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Taehong Choi
- Employees
- 730
- Headquarters
- Seoul, South Korea
- IPO year
- 2018
- Market cap
- ₩166.6B
- Website
- https://www.hanaph.co.kr
Loading 293480…
Loading profile data…Frequently asked questions about 293480
What does Hana Pharm Co., Ltd. (293480.KS) do?
Hana Pharm Co., Ltd. develops and provides various pharmaceutical products in South Korea and internationally. It offers anesthetics, narcotic analgesics, antiemetics, muscle relaxants, cardiovascular and endocrine system, gastrointestinal system, respiratory system, antibiotics, dermatology, urinology, osteoporosis, and central nervous system p...
Where does 293480.KS trade?
Hana Pharm Co., Ltd. (293480.KS) trades on the Korea Exchange.
What sector is 293480.KS in?
Hana Pharm Co., Ltd. (293480.KS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Hana Pharm Co., Ltd.?
Taehong Choi is the chief executive officer of Hana Pharm Co., Ltd. (293480.KS).
Where is Hana Pharm Co., Ltd. headquartered?
Hana Pharm Co., Ltd. is headquartered in South Korea.
Does 293480.KS pay a dividend?
Yes — Hana Pharm Co., Ltd. (293480.KS) paid a trailing twelve-month dividend of KRW 260.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 293480.KS go public?
Hana Pharm Co., Ltd. (293480.KS) completed its initial public offering in 2018.